Abstract
This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of bacillus Calmette-Guérin (BCG) intravesical therapy compared to mitomycin C (MMC) intravesical therapy for treating Ta and T1 bladder cancer in adults.
| Original language | English (US) |
|---|---|
| Article number | CD011935 |
| Journal | Cochrane Database of Systematic Reviews |
| Volume | 2015 |
| Issue number | 11 |
| DOIs | |
| State | Published - Nov 5 2015 |
Bibliographical note
Publisher Copyright:© 2015 The Cochrane Collaboration.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Intravesical bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS